key: cord-0817387-thnu82g9
authors: Ming, D. K.; Sorawat, S.; Chanh, H. Q.; Nhat, P.T.H.; Yacoub, S.; Georgiou, P.; Holmes, A. H.
title: Continuous physiological monitoring using wearable technology to inform individual management of infectious diseases, public health and outbreak responses
date: 2020-06-01
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.05.086
sha: 0c825797452d526559996c180e70f35f5c31072e
doc_id: 817387
cord_uid: thnu82g9

Abstract Optimal management of infectious diseases is guided by up-to-date information at the individual and public health level. For infections of global importance including emerging pandemics such as COVID-19 or prevalent endemic diseases such like dengue, identifying patients at risk of severe disease and clinical deterioration can be challenging given the majority present with a mild illness. In our article, we describe the use of wearable technology for continuous physiological monitoring in healthcare. Deployment of wearables in hospital settings for the management of infectious diseases, or in the community to support syndromic surveillance during outbreaks could provide significant, cost effective advantages and improve healthcare delivery. We highlight a range of promising technologies employed by wearable devices and discuss the technical and ethical issues relating to implementation in the clinic, with specific focus on low- and middle- income countries. Finally, we propose a set of essential criteria for the roll-out of wearable technology for clinical use.

Infectious diseases with major global impact including sepsis, malaria, dengue and emerging viruses commonly give rise to fever and differing degrees of systemic involvement as a result of an underlying inflammatory process. Although presentations differ, severe illness can manifest in common physiological derangements such as haemodynamic shock or hypoxia -their management will often require organ support interventions delivered in intensive care settings. Efficient use of these resources requires a system with the capacity to recognise early physiological derangements in deteriorating patients. However in many acute healthcare settings, particularly within low and middle-income countries (LMICs), implementation of an effective early patient warning system can be difficult (Beane et al. 2018) . Limitations on infrastructure, clinical staffing, high disease prevalence and workload factors can limit effectiveness of healthcare (Schultz et al. 2017) .

Clinical studies have consistently demonstrated need for timely medical interventions; late recognition of illness results in adverse outcomes and increased costs (Judd et al. 2014; Singer et al. 2016 ). There is additionally a complementary need to strengthen frontline community health services to allow for identification and appropriate referral of unwell patients. Maintaining patient referral pathways protect delivery of acute healthcare through improving healthcare integration (Topp et al. 2018) . The importance of health system resilience and preparedness was exemplified in the 2014 West African Ebola epidemic (Siedner et al. 2015) and will be vital in bolstering responses for the 2019 COVID-19 pandemic (Kandel et al. 2020) .

Continuous patient physiological monitoring involves the measurement of parameters such as pulse, electrocardiography, blood pressure, oxygen saturation and respiratory rate through a combination of invasive and non-invasive methods. These parameters guide clinical decisionmaking in many developed healthcare settings however their applicability to LMICs is less defined.

J o u r n a l P r e -p r o o f Expensive equipment costs, need for operator training and low clinical staffing numbers might mean that a direct translation is undesirable (Turner et al. 2019) . In parallel, advances in electrical hardware design and data processing methods have enabled technology capable of detecting multiple aspects of physiology in a continuous, minimally-invasive fashion. Devices which can be worn on the body surface for prolonged periods hold promise particularly for infectious diseases clinical management in LMIC settings by virtue of their relatively low costs and potential for connectivity. Their use in conjunction with rapid diagnostics could strengthening community healthcare and deliver decentralised care, informing public health responses in outbreak settings.

In our article we illustrate the main "wearable" device technologies, describe potential roles in healthcare particularly to LMICs and discuss challenges associated with widespread implementation.

We define a healthcare wearable device as technology which can be appropriately placed on the body by the end-user and capable of monitoring relevant aspects of health to an actionable standard. These devices may obtain data through tracking physiological parameters non-invasively, or sense substrates from body sites in a minimally-invasive fashion. In recent years, the number of consumer grade wearables such as the FitBit™ or Apple Watch™, and devices designed specifically for healthcare use have increased significantly (Dunn et al. 2018) . The main sensing modalities are summarised in table 1 and as follows:

Photoplethysmography (PPG) utilises light reflected from the skin surface in order to noninvasively characterise features of the underlying circulation. PPG is employed widely as pulse cooximetry for the assessment of oxygenated/deoxygenated haemoglobin proportions to derive J o u r n a l P r e -p r o o f oxygen saturation (SpO 2 ) in healthcare settings. Its use in ambulatory and a wearable context has been explored and may aid in management of chronic respiratory conditions (Buekers et al. 2019 ).

In addition there is evidence that parameters, including pulse pressure, respiratory rate and pulse variability as a proxy of autonomic status can also be calculated through analysis of the pulse waveform morphology (Allen 2007). Utilisation of low-cost pulse oximeters coupled with machine learning-driven analysis has been shown to predict onset of autonomic dysfunction in hand-foot and mouth disease (Abebe Tadesse et al. 2020) and tetanus . There is also promising research in estimating fluid status using the PPG waveform alone (Convertino et al. 2013 ) and this has been applied to paediatric patients with dengue shock syndrome . Extension of PPG analysis for the non-invasive measurement of haematocrit is is possible (Phillips et al. 2012 ) and represents an ongoing area of research in dengue (Rodriguez-Manzano et al. 2018) . Although PPG is acceptable by patients, measurement accuracy can be subject to motion artefact and changes in local perfusion. Novel data processing methods which compensate for poor signals can be used to improve signal reliability (Jarchi et al. 2019 ).

Respiratory rate is a sensitive parameter for patient deterioration (Goldhill et al. 1999 ) and measurement of chest expansion can be done through transthoracic impedance. Lung expansion results in a voltage change across the chest surface, and the placement of powered-electrodes on skin can capture changes in electrical impedance. Similarly electrocardiography (ECG) readings can be measured and analysed to derive respiratory rate given the variation of heart rate with respiration (Charlton et al. 2016) . Wearables in the form of a small adhesive skin patch on the chest have undergone clinical studies but with variable performances (Downey et al. 2019; Breteler et al. 2020 ). The assessment of fluid volume status (Covic et al. 2017 ) and cardiac output (Cotter et al. J o u r n a l P r e -p r o o f 2004) through bioimpedance has been shown to be feasible clinically and remains an ongoing area of research.

Biosensing refers to the specific detection of substrates in the body through a variety of methods including enzymatic, antibody and electrochemical approaches (Kim et al. 2019) . Developments in microfluidics also mean that laboratory analyses traditionally performed on blood samples can utilise small volumes of accessible-fluids such as saliva or sweat at the point-of-care. A particularly promising avenue of biosensing has been pioneered in continuous glucose measurement of interstitial fluid (ISF). The ISF is in direct communication with blood and allows for unrestricted diffusion of small molecules. Use of the continuous glucose monitor over 24 weeks resulted in improvements in glycaemic control in patients (Beck et al. 2017) . A phase I study using a microneedle platform -a small minimally-invasive skin patch to measure ISF beta-lactam concentrations -also demonstrated promising results in healthy volunteers with good acceptability . Continuous detection of substrates like lactate using the same microneedle platform is possible (Bollella et al. 2019 ) and could be used guide therapy in malaria (Aramburo et al. 2018) , sepsis (Gu et al. 2015) and dengue (Yacoub et al. 2017 ) without laboratory testing.

Other existing sensor modalities which utilise 3-axis accelerometery, skin temperature, pressure and light may also be combined in a multi-modal fashion to improve specificity.

Continuous patient monitoring methods are likely to improve healthcare providing they are cost effective and perform at a clinically-appropriate standard (DeVita et al. 2010) . We propose that low-cost healthcare wearable devices along with rapid diagnostics could fulfil multiple roles for J o u r n a l P r e -p r o o f infectious diseases management (see figure 1 ). Wearables allow for earlier detection of clinical deterioration in hospital: a PPG-based device measuring pulse waveform alone resulted in earlier recognition of shock in trauma patients (Stewart et al. 2016) . The use of machine learning algorithms to process continuous physiological signals in real-time could provide predictive alerts directly to clinicians (Daniels and Georgiou 2019) . Biosensor devices which detect specific substrates directly from the body provide additional information for risk stratification, without delays or costs associated with laboratory testing. For infectious diseases with a high potential for nosocomial transmission such as COVID-19, pandemic influenza or Ebola, the ability to monitor for early markers of deterioration without direct clinical staff contact and exposure is distinctly advantageous (Steinhubl et al. 2016 ). Data connectivity from multiple patients to a single point could improve resource and time utilisation through identifying sick patients earlier, particularly in a resource-limited setting with low staffing. Efforts using open-source technologies to development such interfaces are underway (Badgeley et al. 2016) . Data from wearable sources can be integrated with other healthcare data through clinical decision support systems to guide specific appropriate responses, such as antimicrobial therapy (Hernandez et al. 2017 ).

Healthcare wearable devices acceptable for prolonged use could lead to opportunities in ambulatory patient management and telemedicine. For example, clinical prediction of severe disease in dengue is difficult and patients who are otherwise well usually return to the clinic for daily assessments, imposing demands on often-strained healthcare systems (Yacoub and Wills 2014) . A PPG-based wearable which can continuously monitor parameters such as pulse, body movement and haematocrit could be provided for home use, and yield actionable information and identify those at high risk. Non-invasive methods of measurement through wearables are particularly suited for paediatric patients where acceptability is likely higher compared with blood testing.

Connectivity of wearable devices and scope for scalability could also augment effectiveness of syndromic surveillance. Communication infrastructure exist in most areas of the world and together with rapid diagnostics connectivity (Ming et al. 2019 ) could facilitate studies into transmission dynamics of infections using location information (Barrat et al. 2014 ).

Implementation of device-based syndromic monitoring which detect physiological derangements could be employed in high-risk scenarios. Individuals in proximity of case clusters for acute respiratory illnesses such as COVID-19 and those at particular risk could be monitored in the community using wearables. These in turn can inform deployment of appropriate rapid diagnostics or public health interventions. In one example, through use of heart rate data from a consumer wearable, researchers in the United States were able to forecast influenza like illness activity which matched with surveillance data (Radin et al. 2020) . Coupling wearables with mHealth technologies such mobile phone messaging for case reporting, geolocation and short-range connectivity through Bluetooth might augment contact tracing and map transmission clusters in outbreaks -one such implementation using mobile phones is planned for deployment in the UK for COVID-19 with results awaited (NHSX 2020). The performance of these predictive models is likely to continue to improve with better data acquisition from purpose-built low-cost wearables.

Significant changes to patient care will likely occur with continuous physiological monitoring through healthcare wearables, however studies which aim to demonstrate their optimal use are currently lacking. A meta-analysis examining use of continuous versus intermittent monitoring in developed healthcare settings was unable to demonstrate differences in patient outcomes (Cardona-Morrell et al. 2016 ). The authors commented on the heterogeneity in outcome measurements and suboptimal designs in some studies: within healthcare systems with multiple J o u r n a l P r e -p r o o f safety pathways and redundancies, it is possible that added benefit of continuous monitoring lies in their ability to affect decision-making and increase efficacy in patient management. Defining these outcomes measures and developing accurate methods of evaluation will be increasingly important -particularly for LMIC settings where cost effectiveness is a major factor. For hospital studies, randomised studies with outcomes which measure actual clinical benefit of the wearable for the patient, as opposed examining device performance alone will be important (Rodger et al. 2012) . For implementation of wearables for ambulatory and surveillance purposes -a systematic multifaceted approach to evaluate these complex interventions will be needed (Moore et al. 2015) . Selected examples of healthcare wearable devices utilising various sensing modalities are presented in Table   1 -these devices have undergone in-human validation but are by no means exhaustive. Of importance is that clinical design and implementation of these wearables have all been conducted in resource-rich settings which can in turn create intrinsic biases in the dataset. We emphasise a need for dedicated studies to be performed in LMICs where applicability and performance can be evaluated appropriately.

The widespread use of healthcare wearable devices will result in generation of high volumes of individualised, detailed data. Longitudinal datasets will be required to understand and interpret these data. For example, the Precision Medicine Initiative aims to include wearable sensor data linked with health information in over 1 million US participants (Precision Medicine Initiative Working Group 2015). Issues of privacy and data ownership are paramount -it is essential these are anticipated and addressed directly together with patient partnership. Strict legislation will be required for the use of geolocation and tracking data in syndromic surveillance, given that routine metadata could potentially be linked to individual identification (Perez et al. 2018 ).

Ensuring the data rights and privacy of the end user is central to implementation. Appropriate dialogue between developers and end users to ensure co-design, building on frameworks such as the Fair Information Practice Principles will be needed. Dedicated studies on wearable use and J o u r n a l P r e -p r o o f acceptability should take place across LMICs and diverse cultural settings in order to identify and explicitly address concerns of relevant users. Supporting user understanding of the purpose of the wearables, facilitating access to their own data and control on the situations when monitoring takes place and what types of data is shared should be a prerequisite in design. In particular, balancing individual rights to privacy with public health will be particularly important during specific situations, such as use of wearables deployed during disease outbreaks.

Broad principles in the use of novel digital health data are beginning to be crystallised by international bodies such as the WHO 2018 Resolution on Digital Health and EU General Data Protection regulation, outlining issues of governance, data minimisation, consent, accountability, privacy and fairness. However there still remains the need for individual countries to better define their own requirements and establish firm guidelines , and this has resulted in significant inconsistencies on the ethical frameworks governing acceptable use of these digital data (Floridi 2019) . Significant investment in developing expert regulatory capacity is required given differences in digital health with clinical research and potential societal impact. A requirement for transparency in how the data is used could facilitate this, such as through development of national digital repositories and algorithms to enable regulatory review after research has been conducted (Samuel and Derrick 2020) .

In terms of hardware development, use of healthcare wearables remain in relatively early stages of development with improvements in utility and performance still awaited. Power consumption of wearables, limited battery life and need for frequent charging may pose issues for effective implementation. Although stand-alone wearables with direct connectivity to WiFi or cellular networks are ideal, current power requirements remain prohibitive. Current wearables which employ local network connectivity with mobile phones using protocols such as Bluetooth Low Energy likely represent a pragmatic existing compromise in terms of power. Developments in power optimisation such as through algorithms which identify optimal periods of sampling J o u r n a l P r e -p r o o f (Culman et al. 2020 ) may result in more efficient wearables, and might be suitable for lower-risk patient groups in the community. In certain cases, although individual parameters might be insufficient to differentiation between "normal" and "abnormal" physiology, the integration of different signals through a multi-modal approach may also increase specificity of early warning systems. Nonetheless, the risk of false-positives generated by warning devices contribute in turn to alarm fatigue and can hinder the usefulness of such devices. This is particularly important for commercially-available smart devices where poor performing products could erode public trust in wearables and affect the future acceptability (Bonafide et al. 2017) . In order to allow for monitoring of inflammatory levels or therapeutic drug concentrations in chronic conditions such as tuberculosis or deep-seated bacterial infections, healthcare wearables will need to be used for prolonged (weeks to months) periods. Strategies to incorporate additional non-health, lifestyle or social media functionalities to these healthcare wearables may improve user retention rate. This blurring of boundaries between health and commercial aspects of wearables, particularly in terms of data ownership again require better definition.

With these considerations in mind we propose a basic set of parameters for healthcare wearable devices to fulfil prior to implementation in table 2.

Healthcare wearable devices offer great advantages for the management of infectious diseases and precision medicine. The technology is undergoing rapid development however we show that continuous capture of quality, actionable data from individuals is already possible through existing modalities. There are specific challenges to infectious diseases including use of geolocation data for surveillance and implementation in resource limited settings -ensuring data privacy through legislation will be essential for public acceptability and trust. However, the roll-out of healthcare Pulse waveform -SpO2 and heart rate reliably derived.

Additional parameters: Blood pressure, respiratory rate, heart rate variability, haematocrit under development.

Everion (arm) None but monitoring in healthy volunteers showed acceptability (Beeler et al. 2018) , and validation with Holter monitoring (Barrios et al. 2019) .

Prone to artefact created by motion or skin perfusion state. Accuracy varies according to site of measurement with best results from finger.

Study on 69 patients with epilepsy using motion and electrodermal activity sensors on device showed ability to characterise generalised seizure activity (Onorati et al. 2017) .

Pilot study on 20 hospitalised patients showed reasonable concordance with early warning scores derived from nurse-obtained measurements (Weenk et al. 2017) .

Electrical impedance Respiratory rate. Sensium * (chest wall)

Pilot study on 61 patients showed general agreement in heart rate and respiratory rate compared with conventional bedside monitoring (Hernandez-Silveira et al. 2015 ) but a study of 50 medical patients showed lack of agreement with nurse-obtained measurements (Granholm et al. 2016) .

Subject to motion artefact. Volume status assessment through bioimpedance currently a research tool.

Equivital † (chest wall)

None but healthy volunteer validation study with Holter monitoring (Akintola et al. 2016 ).

Electrocardiography ECG activity -heart rate and rhythm Respiratory rate possible.

Lifetouch ▲ (chest wall)

Abstract presentation on use in 19 hospitalised patients at risk of liver decompensation showed relationships with clinical severity and inflammation (Chatterjee et al. 2014) .

Arrhythmias such as atrial fibrillation may affect accuracy of respiratory rate measurement, although signal processing methods possible. VitalPatch ▲ (skin)

Randomised clinical trial of 20 patients to usual care or home monitoring showed wearable use associated with lower costs (Levine et al. 2018 Potential roles for healthcare wearable devices in providing continuous real-time physiological monitoring for: a) hospital setting to provide early warning in clinical deterioration; b) ambulatory patient management or follow up of patients discharged at home; c) deployment to healthy individuals at risk of disease outbreak to provide real-time syndromic surveillance information. The data is connected securely to cloud-based systems and integrated with other sources such as rapid diagnostics and healthcare utilisation data. The information is then used for direct patient monitoring, or aggregated at a public health level for surveillance to inform public health measures. b) Ambulatory patients managed at home, or discharged patients Connectivity: Information used for direct clinical management, disease surveillance and inform predictive models and testing Acceptable for user Suitable for prolonged use in terms of comfort and functionality; offers a desired level of privacy and data ownership for the user Actionable data Provides representative quality data at a level appropriate to inform interventions Accessibility

Allow for secure data linkage and connectivity through approved bodies Adaptable

Scalable for roll out. Cost and functionality adaptable to different healthcare resource settings. 

Multi-modal Diagnosis of Infectious Diseases in the Developing World

Comparative Analysis of the Equivital EQ02 Lifemonitor with Holter Ambulatory ECG Device for Continuous Measurement of ECG, Heart Rate, and Heart Rate Variability: A Validation Study for Precision and Accuracy

Lactate clearance as a prognostic marker of mortality in severely ill febrile children in East Africa

EHDViz: clinical dashboard development using open-source technologies

Measuring contact patterns with wearable sensors: methods, data characteristics and applications to data-driven simulations of infectious diseases

Evaluating the accuracy of heart rate sensors based on photoplethysmography for in-the-wild analysis

Evaluation of the feasibility and performance of early warning scores to identify patients at risk of adverse outcomes in a low-middle income country setting

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial

The Wearing Comfort and Acceptability of Ambulatory Physical Activity Monitoring Devices in Soldiers

Microneedle-based biosensor for minimally-invasive lactate detection

The emerging market of smartphone-integrated infant physiologic monitors

Vital Signs Monitoring with Wearable Sensors in High-risk Surgical PatientsA Clinical Validation Study

Wearable Finger Pulse Oximetry for Continuous Oxygen Saturation Measurements During Daily Home Routines of Patients With Chronic Obstructive Pulmonary Disease (COPD) Over One Week: Observational Study. JMIR Mhealth Uhealth

Effectiveness of continuous or intermittent vital signs monitoring in preventing adverse events on general wards: a systematic review and meta-analysis

An assessment of algorithms to estimate respiratory rate from the electrocardiogram and photoplethysmogram

OC-035 Lifetouch®: A Novel Remote Monitoring Device To Identify Patients With Advanced Cirrhosis Most At Risk Of Decompensation -A Proof Of Concept Study

Estimation of individual-specific progression to impending cardiovascular instability using arterial waveforms

Accurate, noninvasive continuous monitoring of cardiac output by whole-body electrical bioimpedance

Value of bioimpedance analysis estimated "dry weight" in maintenance dialysis patients: a systematic review and meta-analysis

Easing Power Consumption of Wearable Activity Monitoring with Change Point Detection. Sensors (Basel)

A Data-Driven Detection System for Predicting Stress Levels from Autonomic Signals

Identifying the hospitalised patient in crisis

Reliability of a wearable wireless patch for continuous remote monitoring of vital signs in patients recovering from major surgery: a clinical validation study from the TRaCINg trial

Wearables and the medical revolution

Translating Principles into Practices of Digital Ethics: Five Risks of Being Unethical. Philos Technol

Physiological values and procedures in the 24 h before ICU admission from the ward

Respiratory rates measured by a standardised clinical approach, ward staff, and a wireless device

Early lactate clearance-guided therapy in patients with sepsis: a metaanalysis with trial sequential analysis of randomized controlled trials

Supervised learning for infection risk inference using pathology data

Assessment of the feasibility of an ultra-low power, wireless digital patch for the continuous ambulatory monitoring of vital signs

Estimation of respiratory rate from motion contaminated photoplethysmography signals incorporating accelerometry

Bioharness TM Multivariable Monitoring Device: Part. I: Validity

Clinical and economic impact of a quality improvement initiative to enhance early recognition and treatment of sepsis

Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries. The Lancet

Wearable biosensors for healthcare monitoring

Hospital-Level Care at Home for Acutely Ill Adults: a Pilot Randomized Controlled Trial

Transforming Global Health with AI

Connectivity of rapidtesting diagnostics and surveillance of infectious diseases. Bull World Health Organ

Process evaluation of complex interventions: Medical Research Council guidance

State-of-the-art monitoring in treatment of dengue shock syndrome: a case series

COVID-19 contact-tracing app

Multicenter clinical assessment of improved wearable multimodal convulsive seizure detectors

You are your Metadata: Identification and Obfuscation of Social Media Users using Metadata Information

Evaluation of electrical and optical plethysmography sensors for noninvasive monitoring of hemoglobin concentration

Precision Medicine Initiative Working Group. The Precision Medicine Initiative Cohort Program -Building a Research Foundation for 21st Century Medicine

Harnessing wearable device data to improve statelevel real-time surveillance of influenza-like illness in the USA: a population-based study. The Lancet Digital Health

Microneedle biosensors for real-time, minimally invasive drug monitoring of phenoxymethylpenicillin: a first-in-human evaluation in healthy volunteers. The Lancet Digital Health

Diagnostic randomized controlled trials: the final frontier

Improving Dengue Diagnostics and Management Through Innovative Technology. Curr Infect Dis Rep

Defining ethical standards for the application of digital tools to population health research. Bull World Health Organ

Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future

A Pivotal Study to Validate the Performance of a Novel Wearable Sensor and System for Biometric Monitoring in Clinical and Remote Environments

Strengthening the Detection of and Early Response to Public Health Emergencies: Lessons from the West African Ebola Epidemic

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Validation of a portable, deployable system for continuous vital sign monitoring using a multiparametric wearable sensor and personalised analytics in an Ebola treatment centre

The Compensatory Reserve Index Following Injury: Results of a Prospective Clinical Trial

How to assess and prepare health systems in low-and middle-income countries for integration of services-a systematic review

Achieving affordable critical care in low-income and middle-income countries

Continuous Monitoring of Vital Signs Using Wearable Devices on the General Ward: Pilot Study

Cardio-haemodynamic assessment and venous lactate in severe dengue: Relationship with recurrent shock and respiratory distress. PLoS neglected tropical diseases

Predicting outcome from dengue